These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 14000004)

  • 1. Kallikrein, kallidin, kallikrein inhibitors.
    WERLE E; TRAUTSCHOLD I
    Ann N Y Acad Sci; 1963 Feb; 104():117-29. PubMed ID: 14000004
    [No Abstract]   [Full Text] [Related]  

  • 2. Design of kallidin-releasing tissue kallikrein inhibitors based on the specificities of the enzyme's binding subsites.
    Portaro FC; Cezari MH; Juliano MA; Juliano L; Walmsley AR; Prado ES
    Biochem J; 1997 Apr; 323 ( Pt 1)(Pt 1):167-71. PubMed ID: 9173877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analgesic-antipyretic drugs as inhibitors of kallikrein.
    NORTHOVER BJ; SUBRAMANIAN G
    Br J Pharmacol Chemother; 1961 Aug; 17(1):107-15. PubMed ID: 13729628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Isolation and chemistry of kallidin].
    WERLE E; EHRLICHER R; KOEBKE K
    Biochem Z; 1951; 322(1):27-35. PubMed ID: 14858397
    [No Abstract]   [Full Text] [Related]  

  • 5. [On bradykinin, kallidin, and various analogous kinds of biologically active polypeptides].
    MORIYA H
    Tanpakushitsu Kakusan Koso; 1962 Jun; 7():382-6. PubMed ID: 14476151
    [No Abstract]   [Full Text] [Related]  

  • 6. [STRUCTURE AND FUNCTION OF THE BIOLOGICALLY ACTIVE PEPTIDES: BRADYKININ, KALLIDIN, ANGIOTENSIN AND SUBSTANCE P].
    MICHAUD J
    Presse Med (1893); 1964 Oct; 72():2693-8. PubMed ID: 14226744
    [No Abstract]   [Full Text] [Related]  

  • 7. BRADYKININOGEN, ANGIOTENSINOGEN AND KALLIDINOGEN.
    FASCIOLO JC
    Br J Pharmacol Chemother; 1963 Oct; 21(2):250-8. PubMed ID: 14081656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nature of the kallidins released from human plasma by kallikreins and other enzymes.
    WEBSTER ME; PIERCE JV
    Ann N Y Acad Sci; 1963 Feb; 104():91-107. PubMed ID: 13999415
    [No Abstract]   [Full Text] [Related]  

  • 9. [PLASMA-KININS].
    WERLE E
    Munch Med Wochenschr; 1963 Dec; 105():2486-93. PubMed ID: 14132754
    [No Abstract]   [Full Text] [Related]  

  • 10. The synthesis of a biologically active decapeptide having the structure proposed for kallidin II.
    NICOLAIDES ED; DEWALD HA; McCARTHY DA
    Biochem Biophys Res Commun; 1961 Nov; 6():210-2. PubMed ID: 14479512
    [No Abstract]   [Full Text] [Related]  

  • 11. [Bradykinin and Kallidin].
    HOLTZ P; HEICKE B; BARCK S
    Experientia; 1962 Apr; 18():184-5. PubMed ID: 13908606
    [No Abstract]   [Full Text] [Related]  

  • 12. Towards understanding the kallikrein-kinin system: insights from measurement of kinin peptides.
    Campbell DJ
    Braz J Med Biol Res; 2000 Jun; 33(6):665-77. PubMed ID: 10829095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of kinin, kallidin, and bradykinin.
    HOLDSTOCK DJ; MATHIAS AP; SCHACHTER M
    Br J Pharmacol Chemother; 1957 Jun; 12(2):149-58. PubMed ID: 13446366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-salt diet downregulates plasma but not tissue kallikrein-kinin system.
    Hilgenfeldt U; Puschner T; Riester U; Finsterle J; Hilgenfeldt J; Ritz E
    Am J Physiol; 1998 Jul; 275(1):F88-93. PubMed ID: 9689009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [ON THE EFFECT OF BRADYKININ, KALLIDIN AND ELEDOISIN ON THE CAT AND RABBIT INTESTINE IN SITU].
    WINKLER H; BAUER G; GMEINER R
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1965 Apr; 250():459-68. PubMed ID: 14336580
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bradykinin, kallidin and hypertension].
    WERLE E; KEHL R; KOEBKE K
    Biochem Z; 1950; 320(4):372-83. PubMed ID: 14777780
    [No Abstract]   [Full Text] [Related]  

  • 17. ENDOGENEOUS MECHANISMS IN INCREASED VASCULAR PERMEABILITY IN INFLAMMATION.
    HAYASHI H
    Acta Pathol Jpn; 1963 Oct; 13():213-5. PubMed ID: 14195178
    [No Abstract]   [Full Text] [Related]  

  • 18. [APNEA AFTER BRADYKININ AND KALLIDIN].
    GJURIS V; HEICKE B; WESTERMANN E
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1964 Aug; 248():540-51. PubMed ID: 14316389
    [No Abstract]   [Full Text] [Related]  

  • 19. ENDOGENEOUS PERMEABILITY FACTORS AND THEIR INHIBITORS AFFECTING VASCULAR PERMEABILITY IN CUTANEOUS ARTHUS REACTIONS AND THERMAL INJURY.
    HAYASHI H; YOSHINAGA M; KOONO M; MIYOSHI H; MATSUMURA M
    Br J Exp Pathol; 1964 Aug; 45(4):419-35. PubMed ID: 14203198
    [No Abstract]   [Full Text] [Related]  

  • 20. Close similarity and minor differences between bradykinin and kallidin.
    VAN ARMAN CG; MILLER LM
    J Pharmacol Exp Ther; 1961 Mar; 131():366-72. PubMed ID: 13779854
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.